Caruana, Dennis
Wei, Wei
Martinez-Morilla, Sandra
Rimm, David L. https://orcid.org/0000-0001-5820-4397
Reisenbichler, Emily S. https://orcid.org/0000-0002-1570-6538
Article History
Received: 24 May 2019
Accepted: 9 January 2020
First Online: 5 February 2020
Competing interests
: D.R. works or has worked as a consultant to AstraZeneca, Agendia, Agilent, Amgen, Biocept, BMS, Cell Signaling Technology, Cepheid, Diiachi Sankyo, Merck, NanoString, Perkin Elmer, and Ultivue; has equity in PixelGear; and received research funding from AstraZeneca, Cepheid, Lilly, Navigate/Novartis, NextCure, NanoString, Ultivue, and Perkin Elmer. The remaining authors declare that they have no conflict of interest.